Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Goletti

Showing results (301-310 of 310) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 310 results.
The Lancet Regional Health. Europe|December 16, 2025
Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310Martina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
The Lancet Regional Health. Europe|August 18, 2025
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet studyMartina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 21, 2025
Accuracy of VIDAS® TB-IGRA in TB patients and individuals with different thresholds of exposureDelia Goletti, Niaz Banaei, Rahul Batra, et al.
The European Respiratory Journal|May 28, 2020
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 casesMarina Tadolini, Luigi Ruffo Codecasa, José-María García-García, et al.
The European Respiratory Journal|June 27, 2020
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC)Catherine Wei Min Ong, Giovanni Battista Migliori, Mario Raviglione, et al.
Science Advances|November 14, 2020
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortalityJustin Stebbing, Ginés Sánchez Nievas, Marco Falcone, et al.
Emerging Infectious Diseases|September 12, 2020
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020Giovanni Battista Migliori, Pei Min Thong, Onno Akkerman, et al.
The European Respiratory Journal|March 21, 2015
Towards tuberculosis elimination: an action framework for low-incidence countriesKnut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, et al.
The European Respiratory Journal|October 12, 2023
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort, Nicolas Casco, Alberto Levi Jorge, et al.
Autophagy|January 23, 2016
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Daniel J Klionsky, Kotb Abdelmohsen, Akihisa Abe, et al.
Pageof 31

Showing results (301-310 of 310) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 310 results.
The Lancet Regional Health. Europe|December 16, 2025
Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310Martina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
The Lancet Regional Health. Europe|August 18, 2025
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet studyMartina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 21, 2025
Accuracy of VIDAS® TB-IGRA in TB patients and individuals with different thresholds of exposureDelia Goletti, Niaz Banaei, Rahul Batra, et al.
The European Respiratory Journal|May 28, 2020
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 casesMarina Tadolini, Luigi Ruffo Codecasa, José-María García-García, et al.
The European Respiratory Journal|June 27, 2020
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC)Catherine Wei Min Ong, Giovanni Battista Migliori, Mario Raviglione, et al.
Science Advances|November 14, 2020
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortalityJustin Stebbing, Ginés Sánchez Nievas, Marco Falcone, et al.
Emerging Infectious Diseases|September 12, 2020
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020Giovanni Battista Migliori, Pei Min Thong, Onno Akkerman, et al.
The European Respiratory Journal|March 21, 2015
Towards tuberculosis elimination: an action framework for low-incidence countriesKnut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, et al.
The European Respiratory Journal|October 12, 2023
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort, Nicolas Casco, Alberto Levi Jorge, et al.
Autophagy|January 23, 2016
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Daniel J Klionsky, Kotb Abdelmohsen, Akihisa Abe, et al.
Pageof 31